Study "WOHIN": Decision path for discharge planning in patients with dementia as secondary diagnosis in the acute hospital: back to one's own home or move to a care facility?

Study "WOHIN": Decision path for discharge planning in patients with dementia as secondary diagnosis in the acute hospital: back to one's own home or move to a care facility? - Wohin

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013161

Enrollment

Registered

2017-10-26

Start date

2017-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia (ICD-10 F00-F03) F00 F01 F02 F03

Interventions

Group 1: Patients with dementia as secondary diagnosis in the acute hospital, which still resides at home, are accompanied before implementation of a decision path during and after their discharge. Pa

Eligibility

Sex/Gender

All

Age

75 Years to 90 Years

Inclusion criteria

Inclusion criteria: The patient resides in a home environment before hospitalization and has a diagnosed dementia or documented suspicion of dementia. Alternative: The patient resides in a home environment before hospitalization. He / she is 75 years old or older and has a noticeable result in the watch test.

Exclusion criteria

Exclusion criteria: The patient has a psychiatric disorder in his / her medical history. The communication with the patient or an informed person (relative / legal guardian) is not possible due to language barriers. The patient is treated for less than 3 days in the recruiting station. No informed partner is available.

Design outcomes

Primary

Measure	Time frame
To show the procedure of the decision, where a patient with dementia as a secondary diagnosis is discharged; analysis of predictors, which lead to the decision to discharge shortly before the patient is discharged; semi-standardized interviews with clinicians (doctors, nursing staff, social services, therapists), patients themselves (if possible) and their relatives / legal guardians; interview guide redesigned on the researcher's side	—

Measure

Time frame

To show the procedure of the decision, where a patient with dementia as a secondary diagnosis is discharged; analysis of predictors, which lead to the decision to discharge shortly before the patient is discharged; semi-standardized interviews with clinicians (doctors, nursing staff, social services, therapists), patients themselves (if possible) and their relatives / legal guardians; interview guide redesigned on the researcher's side

—

Secondary

Measure	Time frame
For the patient: - self-employment vs. neediness (short iADL assessment scale based on the "New Assessment Authority NBA" for assessing and determining the level of care; degree of care) - neuropsychiatric symptoms easy assessment scale based on the "New Assessment Authority NBA" for assessing and determining the level of care) - psychopharmaceuticals (medication at admission and discharge as well as changes in the course) - hospital treatment (time to the first hospital re-hospitalization (morbidity), death of the patient (mortality), number of rehospitalizations during the investigation period, time of inpatient treatment, time of sojourn in short-term care during the investigation period) - residential situation after discharge - satisfaction (satisfaction with the decision taken to the place of residence after the discharge and satisfaction with the residential situation) - quality of life (Scale Quality of Life in Alzheimer’s Disease (QOL-AD), Question No 13) For the relative / legal guardian: - satisfaction (satisfaction with the decision taken regarding the place of residence after the discharge and satisfaction with the patient's place of residence) - quality of life of the relative / legal guardian (Scale Quality of Life in Alzheimer’s Disease (QOL-AD), Question No 13) Recorded and documented through the semi-standardized interviews the survey takes place with a relative / legal guardian of the patient in the control group as well as in the intervention group shortly before and shortly after the release, as well as in the course of 3 times each in 3-month intervals. The interview guide was redesigned on the researcher's side.	—

Measure

Time frame

For the patient: - self-employment vs. neediness (short iADL assessment scale based on the "New Assessment Authority NBA" for assessing and determining the level of care; degree of care) - neuropsychiatric symptoms easy assessment scale based on the "New Assessment Authority NBA" for assessing and determining the level of care) - psychopharmaceuticals (medication at admission and discharge as well as changes in the course) - hospital treatment (time to the first hospital re-hospitalization (morbidity), death of the patient (mortality), number of rehospitalizations during the investigation period, time of inpatient treatment, time of sojourn in short-term care during the investigation period) - residential situation after discharge - satisfaction (satisfaction with the decision taken to the place of residence after the discharge and satisfaction with the residential situation) - quality of life (Scale Quality of Life in Alzheimer’s Disease (QOL-AD), Question No 13) For the relative / legal guardian: - satisfaction (satisfaction with the decision taken regarding the place of residence after the discharge and satisfaction with the patient's place of residence) - quality of life of the relative / legal guardian (Scale Quality of Life in Alzheimer’s Disease (QOL-AD), Question No 13) Recorded and documented through the semi-standardized interviews the survey takes place with a relative / legal guardian of the patient in the control group as well as in the intervention group shortly before and shortly after the release, as well as in the course of 3 times each in 3-month intervals. The interview guide was redesigned on the researcher's side.

—

Countries

Germany

Contacts

Public ContactNotger Müller

DZNE Deutsches Zentrum für Neurodegenerative Erkrankungen

notger.mueller@dzne.de+49 (0)391-67 24519

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026